Yasmeen Tahira, Hashmi Haleema A, Taj Aisha
Department of Obstetrics and Gynaecology, Liaquat National Hospital, Karachi.
J Coll Physicians Surg Pak. 2013 Oct;23(10):711-4. doi: 10.2013/JCPSP.711714.
To assess the maternal morbidity and mortality and fetal outcome with hepatitis E (HEV) in pregnancy.
Cross-sectional study.
Liaquat National Hospital, Karachi, from May 2008 to April 2010.
Thirty patients admitted at Gynae Ward with serologically proven HEV in pregnancy were included in the study. All these patients were followed during their hospital stay with liver function tests and coagulation profile. Maternal morbidity and mortality and fetal outcome were recorded.
Maximum maternal morbidities were noted in patients who presented in 3rd trimester, both clinically and derangement of haematological and biochemical tests. Out of 30 patients, 08 patients expired with maternal mortality rate of 29.3% and rest were discharged safely. Perinatal mortality rate was 30.3 per 1000 live births.
Hepatitis E runs a fulminant course during pregnancy with very high mortality rate especially during third trimester and postpartum period.
评估妊娠期戊型肝炎(HEV)的孕产妇发病率、死亡率及胎儿结局。
横断面研究。
2008年5月至2010年4月,卡拉奇利亚卡特国家医院。
本研究纳入了30例在妇科病房住院、血清学证实妊娠期感染HEV的患者。所有这些患者在住院期间均接受肝功能检查和凝血指标检查。记录孕产妇发病率、死亡率及胎儿结局。
孕晚期就诊的患者出现的孕产妇并发症最多,包括临床症状以及血液学和生化检查异常。30例患者中,8例死亡,孕产妇死亡率为29.3%,其余患者安全出院。围产儿死亡率为每1000例活产30.3例。
戊型肝炎在妊娠期病情凶险,死亡率极高,尤其是在孕晚期和产后。